Table 2 Significantly altered metabolites with corresponding AUC scores, Younden index, P-value and VIP-score.
From: Targeted metabolomic profiling as a tool for diagnostics of patients with non-small-cell lung cancer
| Ā | Metabolite | Metabolomic panel | AUC score | Younden index | P-value | VIP score |
|---|---|---|---|---|---|---|
1 | ADMA | Urea cycle | 0.80 | 0.51641 | ā<ā0.00001 | 2.27 |
2 | Asp | Amino acids | 0.76 | 0.58881 | ā<ā0.00001 | 1.84 |
3 | C6-DC | Acylcarnitines | 0.76 | 0.54105 | ā<ā0.00001 | 1.67 |
4 | Tryptamine | Tryptophan metabolism | 0.76 | 0.54709 | ā<ā0.00001 | 1.85 |
5 | SDMA | Urea cycle | 0.75 | 0.46616 | ā<ā0.00001 | 1.88 |
6 | Indole-3-carboxaldehyde | Tryptophan metabolism | 0.74 | 0.64726 | ā<ā0.00001 | 1.71 |
7 | Orn | Amino acids | 0.73 | 0.61618 | ā<ā0.00001 | 1.63 |
8 | Phe | Amino acids | 0.70 | 0.5775 | ā<ā0.00001 | 1.48 |
10 | C16-1 | Acylcarnitines | 0.69 | 0.54058 | ā<ā0.00001 | 1.34 |
11 | Cit | Amino acids | 0.69 | 0.58911 | ā<ā0.00001 | 1.47 |
12 | Indole-3-propionic acid | Tryptophan metabolism | 0.69 | 0.615 | ā<ā0.00001 | 1.05 |
13 | C5-OH | Acylcarnitines | 0.68 | 0.54112 | ā<ā0.00001 | 1.32 |
15 | C0 | Acylcarnitines | 0.68 | 0.59459 | ā<ā0.00001 | 1.34 |
16 | Leu | Amino acids | 0.68 | 0.50.641 | ā<ā0.0001 | 1.24 |
17 | C16-1-OH | Acylcarnitines | 0.67 | 0.54207 | ā<ā0.0001 | 1.17 |
18 | Ile | Amino acids | 0.67 | 0.53259 | ā<ā0.0001 | 1.14 |
19 | C16 | Acylcarnitines | 0.66 | 0.53065 | ā<ā0.0001 | 1.16 |
20 | C18-OH | Acylcarnitines | 0.66 | 0.54106 | ā<ā0.0001 | 1.20 |
21 | Quinolinic acid | Tryptophan metabolism | 0.66 | 0.56592 | ā<ā0.0001 | 1.07 |
22 | Choline | Urea cycle | 0.66 | 0.50.109 | ā<ā0.001 | 1.16 |
23 | Lysine | Amino acids | 0.65 | 0.52766 | ā<ā0.001 | 1.20 |
24 | Proline | Amino acids | 0.65 | 0.49426 | ā<ā0.001 | 1.19 |